Intracellular ESAT-6: A new biomarker for Mycobacterium tuberculosis infection

Nikolaos Poulakis1, Angelos D Gritzapis2, Maria Ploussi2,3

  • 1Department of Pulmonary Medicine, Locus Medicus S.A., Athens, Greece.

Abstract

Insights

Intracellular Early secreted antigenic target 6 (ESAT-6) is a promising biomarker for Mycobacterium tuberculosis (MTB) infection. Detection in host cells can aid in evaluating active TB and diagnosing latent TB infection.

Area of Science:

  • Immunology
  • Microbiology
  • Infectious Diseases

Background:

  • Early secreted antigenic target 6 (ESAT-6) is a key virulence factor of Mycobacterium tuberculosis (MTB).
  • Intracellular detection of ESAT-6 (i/cESAT-6) in host cells offers a direct marker for MTB infection.
  • A novel flow cytometry method was developed to detect i/cESAT-6.

Purpose of the Study:

  • To investigate the expression of i/cESAT-6 in host cells of individuals with MTB infection.
  • To assess the diagnostic potential of i/cESAT-6 as a biomarker for tuberculosis.

Main Methods:

  • Examined i/cESAT-6 expression in blood samples from 58 active TB patients, 10 TB-naïve controls, 17 patients who completed treatment, and 56 close contacts.
  • Analyzed i/cESAT-6 in sputum from 12 active TB patients.
  • Utilized flow cytometry for detection.

Main Results:

  • i/cESAT-6 was detected in 90% of active TB patients' blood.
  • 26% of close contacts and 18% of patients who completed treatment showed positive results.
  • All culture-positive TB sputum specimens were positive for i/cESAT-6.

Conclusions:

  • i/cESAT-6 shows promise as a biomarker for MTB infection.
  • It may aid in evaluating active TB and diagnosing latent TB infection.
  • Further research is required to validate its diagnostic utility.